Nazarali Samina, Derfalvi Beata, Clark Pascale
Department of Medicine, Division of Clinical Immunology and Allergy, Western University, London, ON, Canada.
Division of Immunology, Department of Paediatrics, Dalhousie University, IWK Health, Halifax, NS, Canada.
Allergy Asthma Clin Immunol. 2025 Apr 29;21(1):19. doi: 10.1186/s13223-025-00965-4.
X-linked inhibitor of apoptosis (XIAP) deficiency is a rare inborn error of immunity which occurs secondary to mutations in the XIAP/BIRC4 gene. Disease onset usually manifests within the first few years of life, and is associated with a spectrum of clinical features, secondary to immune dysregulation. Males typically present with refractory chronic colitis, hemophagocytic lymphohistiocytosis, and severe and/or recurrent infections. Laboratory analysis may reveal hypogammaglobulinemia and cytopenias. At present, the only curative treatment is allogenic hematopoietic stem cell transplantation.
A 24-year-old gentleman, immigrant from the Democratic Republic of Congo, was referred to outpatient immunology for evaluation of an inborn error of immunity given a past medical history significant for refractory fistulizing Crohn's disease, arthritis, liver abscesses, prior disseminated tuberculosis, anemia, and recurrent infections. He had been asymptomatic throughout his childhood and adolescence, with no infections or symptoms of inflammatory disease until the age of 19, when he was diagnosed with Crohn's disease. He was soon after admitted to hospital and was diagnosed with hemophagocytic lymphohistiocytosis. Primary immunodeficiency gene panel testing revealed a nonsense variant XIAP c833C > G p.(Ser278*), which generates a premature stop codon at exon 2 (of total 7 exons). On flow cytometry analysis, XIAP protein expression was significantly reduced, confirming the diagnosis of XIAP deficiency.
This is one of the only documented reports of a patient with XIAP deficiency, presenting with symptom-onset in adulthood. This case highlights the need to maintain a high index of suspicion for XIAP deficiency in patients with the appropriate clinical presentation, despite advanced age of presentation.
X连锁凋亡抑制蛋白(XIAP)缺乏症是一种罕见的先天性免疫缺陷病,继发于XIAP/BIRC4基因突变。疾病通常在生命的最初几年发病,并与一系列临床特征相关,这些特征继发于免疫失调。男性通常表现为难治性慢性结肠炎、噬血细胞性淋巴组织细胞增生症以及严重和/或反复感染。实验室分析可能显示低丙种球蛋白血症和血细胞减少。目前,唯一的治愈性治疗方法是异基因造血干细胞移植。
一名24岁的男性,来自刚果民主共和国的移民,因有难治性瘘管性克罗恩病、关节炎、肝脓肿、既往播散性结核病、贫血和反复感染等病史,被转诊至门诊免疫科评估先天性免疫缺陷病。他在童年和青少年时期一直无症状,直到19岁被诊断为克罗恩病之前,没有感染或炎症性疾病的症状。此后不久他入院并被诊断为噬血细胞性淋巴组织细胞增生症。原发性免疫缺陷基因检测显示XIAP基因存在无义变异c833C>G p.(Ser278*),该变异在第2外显子(共7个外显子)处产生一个过早的终止密码子。流式细胞术分析显示,XIAP蛋白表达显著降低,确诊为XIAP缺乏症。
这是仅有的几例记录在案的XIAP缺乏症患者报告之一,且症状在成年期出现。该病例强调,尽管患者发病年龄较大,但对于具有适当临床表现的患者,仍需高度怀疑XIAP缺乏症。